Jill S. Lindberg

Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis

Jill S. Lindberg, Bruce F. Culleton, Gordon Tin Chun Wong et al. · Journal of the American Society of Nephrology · 2005 · 407 citations

19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis.

Kévin Martin, E. A. González, Mary Gellens et al. · Journal of the American Society of Nephrology · 1998 · 344 citations

Hemodialysis, Urology, Medicine +13

A Longitudinal Study of Uremic Pruritus in Hemodialysis Patients

Vandana Mathur, Jill S. Lindberg, Michael J. Germain et al. · Clinical Journal of the American Society of Nephrology · 2010 · 310 citations · Full text

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism

Jill S. Lindberg, Sharon M. Moe, William G. Goodman et al. · Kidney International · 2003 · 235 citations

Secondary Hyperparathyroidism, Urology, Physiology +8

Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients

Allen R. Nissenson, Suzanne K. Swan, Jill S. Lindberg et al. · American Journal of Kidney Diseases · 2002 · 213 citations

Hemodialysis, Darbepoetin Alfa, Renal Function +9